Viewing Study NCT04868760


Ignite Creation Date: 2025-12-25 @ 2:17 AM
Ignite Modification Date: 2026-02-06 @ 12:34 AM
Study NCT ID: NCT04868760
Status: COMPLETED
Last Update Posted: 2025-04-13
First Post: 2021-04-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Similarity in Pharmacokinetics and Safety of IBI310 and Ipilimumab(YERVOY)in Adult Healthy Chinese Male Volunteers
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Subjects View
Keywords: